EUVIMEDEUVIMED entdecken
Crossref

Metabolic Profiles of Type 2 Diabetes and Their Association With Renal Complications

Shen Li iD, Mengxuan Cui iD, Yingshu Liu iD, Xuhan Liu, Lan Luo, Wei Zhao, Xiaolan Gu, Linfeng Li iD, Chao Liu iD, Lan Bai, Di Li, Bo Liu iD und 4 weitere

The Journal of Clinical Endocrinology & Metabolism · 2024

DOI: 10.1210/clinem/dgad643 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Shen Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Central Laboratory, Central Hospital of Dalian University of Technology, Dalian 116000, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Kidney Failure, Chronic, Diabetic Nephropathies, Metabolic Syndrome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Key R&D Program of China, Dalian Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

The components of metabolic syndrome (MetS) are interrelated and associated with renal complications in patients with type 2 diabetes (T2D).

Objective

We aimed to reveal prevalent metabolic profiles in patients with T2D and identify which metabolic profiles were risk markers for renal progression.

Methods

A total of 3556 participants with T2D from a hospital (derivation cohort) and 931 participants with T2D from a community survey (external validation cohort) were included. The primary outcome was the onset of diabetic kidney disease (DKD), and secondary outcomes included estimated glomerular filtration rate (eGFR) decline, macroalbuminuria, and end-stage renal disease (ESRD). In the derivation cohort, clusters were identified using the 5 components of MetS, and their relationships with the outcomes were assessed. To validate the findings, participants in the validation cohort were assigned to clusters. Multivariate odds ratios (ORs) of the primary outcome were evaluated in both cohorts, adjusted for multiple covariates at baseline.

Results

In the derivation cohort, 6 clusters were identified as metabolic profiles. Compared with cluster 1, cluster 3 (severe hyperglycemia) had increased risks of DKD (hazard ratio [HR] [95% CI]: 1.72 [1.39-2.12]), macroalbuminuria (2.74 [1.84-4.08]), ESRD (4.31 [1.16-15.99]), and eGFR decline [P < .001]; cluster 4 (moderate dyslipidemia) had increased risks of DKD (1.97 [1.53-2.54]) and macroalbuminuria (2.62 [1.61-4.25]). In the validation cohort, clusters 3 and 4 were replicated to have significantly increased risks of DKD (adjusted ORs: 1.24 [1.07-1.44] and 1.39 [1.03-1.87]).

Conclusion

We identified 6 prevalent metabolic profiles in patients with T2D. Severe hyperglycemia and moderate dyslipidemia were validated as significant risk markers for DKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Kidney Failure, ChronicDiabetic NephropathiesMetabolic SyndromeDyslipidemiasHyperglycemiaHumansGlomerular Filtration RateMetabolome

Stichwörter der Autor:innen

diabetic kidney diseaseeGFR declineend-stage renal diseasemetabolic syndrometype 2 diabetes

Autor:innen und Institutionen

  • Department of Central Laboratory, Central Hospital of Dalian University of Technology, Dalian 116000, China.
  • Yidu Cloud Technology Inc, Beijing 100101, China.
  • Department of Endocrinology, Central Hospital of Dalian University of Technology, Dalian 116000, China.
  • Department of Neurointervention, Central Hospital of Dalian University of Technology, Dalian 116000, China.
  • School of Biomedical Engineering, Dalian University of Technology, Dalian 116024, China.
  • Department of Medical Equipment, Central Hospital of Dalian University of Technology, Dalian 116000, China.

ORCID-Profile: Shen Li, Mengxuan Cui, Yingshu Liu, Linfeng Li, Chao Liu, Bo Liu, Yao Wang, Zhengnan Gao

Förderung

  • National Key R&D Program of China
  • Dalian Science and Technology Bureau

Zitieren

APA

Li, S., Cui, M., Liu, Y., Liu, X., Luo, L., Zhao, W., Gu, X., Li, L., Liu, C., Bai, L., Li, D., Liu, B., Che, D., Li, X., Wang, Y., & Gao, Z. (2024). Metabolic Profiles of Type 2 Diabetes and Their Association With Renal Complications. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad643

Vancouver

Li S, Cui M, Liu Y, Liu X, Luo L, Zhao W, et al. Metabolic Profiles of Type 2 Diabetes and Their Association With Renal Complications. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgad643

BibTeX
@article{Li2024,
  author = {Li, Shen and Cui, Mengxuan and Liu, Yingshu and Liu, Xuhan and Luo, Lan and Zhao, Wei and Gu, Xiaolan and Li, Linfeng and Liu, Chao and Bai, Lan and Li, Di and Liu, Bo and Che, Defei and Li, Xinyu and Wang, Yao and Gao, Zhengnan},
  title = {Metabolic Profiles of Type 2 Diabetes and Their Association With Renal Complications},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  doi = {10.1210/clinem/dgad643}
}
Kostenlos starten →